370 related articles for article (PubMed ID: 28465421)
1. Hyperactive locomotion in a
Kashima R; Redmond PL; Ghatpande P; Roy S; Kornberg TB; Hanke T; Knapp S; Lagna G; Hata A
Sci Signal; 2017 May; 10(477):. PubMed ID: 28465421
[TBL] [Abstract][Full Text] [Related]
2. Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome.
Kashima R; Roy S; Ascano M; Martinez-Cerdeno V; Ariza-Torres J; Kim S; Louie J; Lu Y; Leyton P; Bloch KD; Kornberg TB; Hagerman PJ; Hagerman R; Lagna G; Hata A
Sci Signal; 2016 Jun; 9(431):ra58. PubMed ID: 27273096
[TBL] [Abstract][Full Text] [Related]
3. Wnd/DLK Is a Critical Target of FMRP Responsible for Neurodevelopmental and Behavior Defects in the Drosophila Model of Fragile X Syndrome.
Russo A; DiAntonio A
Cell Rep; 2019 Sep; 28(10):2581-2593.e5. PubMed ID: 31484070
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate rescues neuronal defects in the Drosophila model of Fragile X Syndrome.
Hutson RL; Thompson RL; Bantel AP; Tessier CR
Life Sci; 2018 Feb; 195():65-70. PubMed ID: 29317220
[TBL] [Abstract][Full Text] [Related]
5. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
[TBL] [Abstract][Full Text] [Related]
7. Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.
Siller SS; Broadie K
Dis Model Mech; 2011 Sep; 4(5):673-85. PubMed ID: 21669931
[TBL] [Abstract][Full Text] [Related]
8. Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype.
Klemmer P; Meredith RM; Holmgren CD; Klychnikov OI; Stahl-Zeng J; Loos M; van der Schors RC; Wortel J; de Wit H; Spijker S; Rotaru DC; Mansvelder HD; Smit AB; Li KW
J Biol Chem; 2011 Jul; 286(29):25495-504. PubMed ID: 21596744
[TBL] [Abstract][Full Text] [Related]
9. Fragile X Mental Retardation Protein positively regulates PKA anchor Rugose and PKA activity to control actin assembly in learning/memory circuitry.
Sears JC; Choi WJ; Broadie K
Neurobiol Dis; 2019 Jul; 127():53-64. PubMed ID: 30771457
[TBL] [Abstract][Full Text] [Related]
10. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Henderson C; Wijetunge L; Kinoshita MN; Shumway M; Hammond RS; Postma FR; Brynczka C; Rush R; Thomas A; Paylor R; Warren ST; Vanderklish PW; Kind PC; Carpenter RL; Bear MF; Healy AM
Sci Transl Med; 2012 Sep; 4(152):152ra128. PubMed ID: 22993295
[TBL] [Abstract][Full Text] [Related]
11. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
12. The state of synapses in fragile X syndrome.
Pfeiffer BE; Huber KM
Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
[TBL] [Abstract][Full Text] [Related]
14. ESCRT-III Membrane Trafficking Misregulation Contributes To Fragile X Syndrome Synaptic Defects.
Vita DJ; Broadie K
Sci Rep; 2017 Aug; 7(1):8683. PubMed ID: 28819289
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
[TBL] [Abstract][Full Text] [Related]
16. The Drosophila FMRP and LARK RNA-binding proteins function together to regulate eye development and circadian behavior.
Sofola O; Sundram V; Ng F; Kleyner Y; Morales J; Botas J; Jackson FR; Nelson DL
J Neurosci; 2008 Oct; 28(41):10200-5. PubMed ID: 18842880
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous motor-behavior abnormalities in two
Andrew DR; Moe ME; Chen D; Tello JA; Doser RL; Conner WE; Ghuman JK; Restifo LL
J Neurogenet; 2021 Mar; 35(1):1-22. PubMed ID: 33164597
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
19. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Bhattacharya A; Kaphzan H; Alvarez-Dieppa AC; Murphy JP; Pierre P; Klann E
Neuron; 2012 Oct; 76(2):325-37. PubMed ID: 23083736
[TBL] [Abstract][Full Text] [Related]
20. The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1.
Xu K; Bogert BA; Li W; Su K; Lee A; Gao FB
Curr Biol; 2004 Jun; 14(12):1025-34. PubMed ID: 15202995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
